Co-Diagnostics
CODX
CODX
45 hedge funds and large institutions have $16.3M invested in Co-Diagnostics in 2020 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
45
Holders Change
+35
Holders Change %
+350%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
40
Increased
2
Reduced
1
Closed
3
Calls
$5.42M
Puts
$1.78M
Net Calls
+$3.64M
Net Calls Change
+$3.64M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$2.8M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$5.92M |
| 3 |
3
Millennium Management
New York
|
$791K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$773K |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$924K |
Top Sellers
| 1 |
1
HighTower Advisors
Chicago,
Illinois
|
$250K |
| 2 |
2
Barclays
London,
United Kingdom
|
$0 |
| 3 |
3
Renaissance Technologies
New York
|
$0 |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$0 |